Your browser doesn't support javascript.
loading
Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer.
Huang, Mingyan; Luo, Jianhua; Ji, Xinpei; Hu, Miao; Xue, Yiquan; Liu, Qiuyan.
Afiliación
  • Huang M; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China.
  • Luo J; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China.
  • Ji X; Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Hu M; Department of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
  • Xue Y; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China.
  • Liu Q; National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, China. Electronic address: liuqy@immunol.org.
Pharmacol Res ; 186: 106512, 2022 12.
Article en En | MEDLINE | ID: mdl-36272639
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígenos B7 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígenos B7 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China